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Background: Hypotension remains a common clinical problem of spinal anesthesia for cesarean delivery and 
phenylephrine is used as a vasopressor to address this. However, phenylephrine reduces maternal cardiac output 
(CO) due to reflex bradycardia. Glycopyrrolate is safe for the fetus, and increases heart rate (HR). Using a noninvasive 
measure of CO, we compared maternal hemodynamic changes between the phenylephrine only group (group P) and 
the phenylephrine plus glycopyrrolate group (group PG).
Methods: In this randomized study, 60 women scheduled for elective cesarean delivery were allocated to group P (n 
= 30) or group PG (n = 30). In both groups, phenylephrine was infused at 50 μg/min. This infusions stopped if systolic 
blood pressure (SBP) was higher than the baseline value, and phenylephrine 100 μg was injected if SBP was lower 
than 80% of the baseline value from spinal anesthesia to delivery. In group PG, glycopyrrolate 0.2 mg was injected 
intravenously after spinal anesthesia. Hemodynamic parameters, such as SBP, heart rate (HR), stroke volume index 
(SVI), cardiac index (CI) were measured before and until 15 min after spinal anesthesia.
Results: There were no significant differences in SBP and SVI compared to the baseline value in each group and 
between the two groups. HR and CI reduced significantly from 8 min to 15 min in group P compared to the baseline 
value as well as group PG for each time-point. However, HR and CI were maintained in group PG.
Conclusions: The use of glycopyrrolate added to phenylephrine infusion to prevent hypotension by spinal anesthesia 
for cesarean delivery was effective in maintaining HR and CI. (Korean J Anesthesiol 2012; 62: 35-39)
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Introduction
Despite many studies, hypotension during regional anesthesia 
for cesarean section is a common clinical problem. An essential 
measure is the use of vasopressors with preloading for pre-
venting hypotension during regional anesthesia. The recent 
trend of vasopressor use is reduction of ephedrine preference. 
This is because ephedrine is associated with lower fetal pH 
and combinations of phenylephrine and ephedrine appear to 
have no advantage compared with phenylephrine alone [1]. 
Instead, phenylephrine infusion alone is established as a first-
line vasopressor, because it does not appear to be harmful to 
the fetus when given in the dose range required to prevent 
hypotension, and be effective for hemodynamic control [2]. 
However, it reduces maternal cardiac output (CO) due to reflex 
bradycardia [3]. Therefore, this study was designed to compare 
phenylephrine infusion alone with phenylephrine infusion 
combined with glycopyrrolate to observe whether maternal 
CO was maintained by anticholinergic boluses during spinal 
anesthesia for cesarean section. 
Materials and Methods
The study was reviewed and approved by the Cheil General 
Hospital institutional review board, and informed consent 
was obtained from each patient. Sixty consecutive women 
scheduled for elective cesarean section under spinal anesthesia 
were approached for the study. Exclusion criteria included 
cardiovascular or cerebrovascular disease, pregnancy-related 
hypertensive disease, height < 150 cm or > 180 cm, weight < 50 
kg or > 100 kg, known fetal abnormalities, contraindications to 
glycopyrrolate, fever, twin pregnancies, and diabetes mellitus
Randomization was performed using an Excel (Microsoft, 
USA) generated numbers. Parturients were randomly assigned 
to the phenylephrine only group (group P) or the phenylephrine 
combined with glycopyrrolate group (group PG). The patients 
had no premedication prior to the study. On arrival in the 
operating room, we tilted the operating table to the left by up to 
15
o and permitted the patients to rest undisturbed in the supine 
position for several minutes. Then we measured SBP and HR 
three times. Baseline SBP and HR were taken as the mean 
value of three recordings. We measured baseline CI and SVI 
simultaneously using a noninvasive cardiac output measuring 
device (Solar8000M, GE, USA). 
With Hartmann solution fully loaded, we initiated spinal 
anesthesia. Spinal anesthesia was induced with patients in the 
left lateral position at the L3-4 or L4-5 vertebral interspace and 
0.5% hyperbaric bupivacaine 10 mg and fentanyl 15 μg were 
injected intrathecally using a 25-gauge pencil point needle 
(25Pencan
Ⓡ, B/Braun, Germany).
After spinal anesthesia, the phenylephrine was infused at 
a rate of 50 μg/min in each group and glycopyrrolate was IV 
injected in group PG at the same time. We recorded systolic 
blood pressure (SBP), heart rate (HR), stroke volume index (SVI), 
cardiac index (CI) at 1 min intervals for 15 min. Hartmann 
solution was fully loaded for 15 min without exceeding 1,000 
ml. The phenylephrine was infused at a rate of 50 μg/min for 
15 min and the hemodynamic values were recorded. If the SBP 
was above the baseline, the infusion was stopped, and if it was 
at or below the baseline, the infusion was continued. After 15 
min, we determined phenylephrine infusion rate within 80 % of 
baseline SBP maintenance. 
Hypotension, defined as a SBP ≤ 80% of baseline SBP for 2 
consecutive readings, despite the phenylephrine infusion, was 
treated with a bolus of phenylephrine 100 μg if HR > 60 bpm 
and a bolus of ephedrine 10 mg if HR < 60 bpm. Bradycardia, 
defined as HR < 50 bpm for 2 consecutive readings, was treated 
by stopping the phenylephrine infusion if the SBP was at or 
above the baseline. However, if the SBP was below the baseline, 
the phenylephrine infusion was continued and a bolus of 
ephedrine 10 mg was administered. Total phenylephrine 
infusion dose was recorded for 15 min including bolus dose. 
Five minutes after intrathecal injection, we measured the upper 
sensory level of anesthesia by assessing loss of pinprick dis-
crimination. We recorded skin incision time, uterine incision 
time, delivery time and measured each interval. The incision 
was delayed for the study until 15 minute after obtaining 
obstetrician agreement. After delivery, Apgar scores 1 and 5 min 
were recorded. Phenylephrine rescue and ephedrine rescue 
numbers were recorded.
Data were expressed as mean ± SD or median or number of 
patients. For statistical analysis, Sigma Stat software (version 
3.5, IL, USA) was used. One-way repeated measures ANOVA 
with Bonferroni test was used for comparison of SBP, HR, SVI, 
and CI within each group. The student t test and Mann-Whitney 
rank sum test were used for measurements between the two 
groups. A P value of less than 0.05 was considered statistically 
significant.
Results
There were no statistical differences in demographic data 
and baseline cardiovascular values between the two groups 
(Table 1, 2, respectively). There were no statistical differences in 
experimental data between the two groups either (Table 3).
There was, however, a statistically significant decrease in HR 
at 8 min compared with the baseline values, which continued 
until 15 min in group P. There was a no significant difference 
in group PG. There was a significant decrease from 8 min to 15 
min in group P compared with group PG (Fig. 1). There was no 37 www.ekja.org
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significant difference in SVI compared with baseline values in 
each group and between the two groups (Fig. 2), but there was a 
statistically significant decrease in CI at 8 min compared to the 
baseline values, which continued until 15 min in group P, and 
there was a no significant difference in group PG. There was a 
significant decrease from 8 min to 15 min in group P compared 
with group PG (Fig. 3), but there was a no significant difference 
in SBP compared with baseline values in each group and 
between the two groups (Fig. 4).
Discussion
Hypotension during regional anesthesia for cesarean section 
is a very common and severe clinical problem. Factors con-
Table 1. Maternal Characteristics
Group P (n = 30) Group PG (n = 30)
Age (year)
Weight (kg)
Height (cm)
33 ± 3
73 ± 7
162 ± 4
34 ± 4
70 ± 8
162 ± 4
Values are mean ± SD. There were no significant differences 
between groups. Group P: phenylephrine alone group. Group PG: 
phenylephrine plus glycopyrrolate group.
Table 2. Baseline Cardiovascular Values
Group P 
(n = 30)
Group PG 
(n = 30)
Heart rate (bpm)
Cardiac index (l/min/m
2)
Systolic blood pressure (mmHg)
Stroke volume index (ml/m
2)
81 ± 9
3.1 ± 0.4
115 ± 11
38.5 ± 6.5
79 ± 13
3.0 ± 0.4
112 ± 8
38.9 ± 5.5
Values are mean ± SD. There were no significant differences between 
groups. Group P: phenylephrine alone group. Group PG: pheny-
lephrine plus glycopyrrolate group.
Table 3. Experimental Data
Group P (n = 30) Group PG (n = 30)
Total fluid intake (ml)
Total phenylephrine infusion dose (μg)
No. of patients of bradycardia (n)
No. of patients receiving phenylephrine rescue (n)
No. of patients receiving ephedrine rescue (n)
Maximal block height
Apgar score 1
Apgar score 5
spinal injection to skin incision interval (min)
skin incision to uterine incision interval (min)
uterine incision to delivery interval (min)
593 ± 127
552 ± 118
2
5
1
T3 (T2-T5)
8 (7-9)
9 (8-10)
17.3 ± 3.4
4.9 ± 2.1
1.5 ± 1.0
611 ± 109
501 ± 154
0
4
1
T3 (T2-T5)
8 (6-9)
9 (8-10)
19.2 ± 7.3
4.7 ± 1.7
2.0 ± 1.8
Values are mean ± SD, number, or median. There were no significant differences between groups. Group P: phenylephrine alone group. Group 
PG: phenylephrine plus glycopyrrolate group.
Fig. 1. Heart rate changes during 15 minutes after spinal anesthesia. 
HR: heart rate. Group P: phenylephrine alone group. Group PG: 
phenylephrine plus glycopyrrolate group. *P < 0.05 compared to 
baseline value in group P. 
†P < 0.05 compared with group PG.
Fig. 2. Stroke volume index changes during 15 minutes after spinal 
anesthesia. SVI: Stroke volume index. Group P: phenylephrine alone 
group. Group PG: phenylephrine plus glycopyrrolate group.38 www.ekja.org
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tributing to this include increased sensitivity to local anesthetics, 
aortocaval compression and increased suscepti  bility to the 
effects of sympathetic block [2]. Hypotension may cause 
nausea and vomiting, and long-term, severe hypotension may 
cause unconsciousness, pulmonary aspiration, hypoxia and 
acidosis, as well as Fetal neurological injury due to reduction 
of uteroplacental blood flow [4]. Management of hypotension 
during regional anesthesia includes positional change, fluid 
therapy, vasopressors, and other non  pharmacological methods 
[2]. Although positional change by tilt or wedge is considered to 
be necessary, this management does not prevent hypotension 
by aortocaval compression completely [5]. In addition, although 
colloids appear to be more effective than crystalloids [6], the 
decision to use them depends on individual assessment of 
benefits compared with potential disadvantages. 
Recent studies compared prehydration with cohydration of 
colloids and there were only a few differences in hemodynamic 
change and vasopressin requirement [7-9]. Positional change 
and fluid loading did not prevent hypotension completely, 
which required other methods including vasopressor. Arai et al. 
[10] found that transcutaneous electrical nerve stimulation at 
the Neiguan (PC-6) and Jianshi (PC-5) acupoints resulted in less 
hypotension and vasopressin requirement than the controls. 
Bjørnestad et al. [11] compared wrapping the legs with tight 
elastic bandages and applying intravenous boluses of pheny-
lephrine 50 mg, given immediately and at 5 and 10 min after 
epidural block. They found no difference between groups in the 
incidence of hypotension. However, these techniques have not 
found wide acceptance in clinical practice.
There are many studies of alpha agonists like phenylephrine, 
which is now a trend in choice of vasopressors for preventing 
hypotension during regional anesthesia. In phenylephrine and 
ephedrine infusion combination studies, as the proportion 
of phenylephrine decreased and the proportion of ephedrine 
increased, the incidence of hypotension and nausea/vomiting 
increased and fetal pH and base excess reduced [1]. However, 
the ideal method of administration and dosing regimen for 
phenylephrine is controversial. Infusions titrated in the range 
of 25-100 μg/min are effective for maintaining maternal BP 
[12]. Phenylephrine does not appear to be harmful to the fetus 
when given in the dose range required to prevent hypotension 
and is highly effective [2]. However, phenylephrine cause 
reflex decreases in HR and reduce CO [3,13]. As the dosage of 
phenylephrine increase, BP maintenance is more effective but 
CO becomes more reduced. The role of reduced CO is unclear in 
clinical settings. Most studies of vasopressors have been made 
in healthy low-risk elective patients, so that the clinical impact 
of CO reduction caused by phenylephrine infusion is unclear. 
Ngan Kee et al. [14] reported that neonatal outcome and acid-
base status was similar between two groups having non-elective 
spinal caesarean section to receive either phenylephrine or 
ephedrine boluses to treat hypotension including potential 
fetal compromise. However, CO reduction may result in the 
reduction of uteroplacental blood flow, and the impact may 
result in harmful influence on a potentially compromised fetus 
with reduced margin of safety for uteroplacental perfusion. 
Therefore, the measures compensating for CO reduction can 
become an ideal regimen.
CO reduction caused by phenylephrine administration 
is due to reduction of HR, but the stroke volume is well 
maintained [13]. Therefore, we assumed that anticholinergics 
maintain HR and CO. Although among anticholinergics, 
atropine is more effective than glycopyrrolate for HR increase, 
Fig. 4. Systolic blood pressure changes during 15 minutes after spinal 
anesthesia. SBP: Systolic blood pressure. Group P: phenylephrine 
alone group. Group PG: phenylephrine plus glycopyrrolate group.
Fig. 3. Cardiac index changes during 15 minutes after spinal 
anesthesia. CI: cardiac index. Group P: phenylephrine alone group. 
Group PG: phenylephrine plus glycopyrrolate group. *P < 0.05 
compared to baseline value in group P. 
†P < 0.05 compared with 
group PG.39 www.ekja.org
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the placental transfer rate of atropine (F/M ratio; 0.93) is more 
than glycopyrrolate (F/M ratio; 0.22). Therefore, glycopyrrolate 
was predicted to be a safe drug to pregnant women because of 
significantly reduced effects on the fetus [15]. Glycopyrrolate 
has a longer duration of action than atropine [16], and the 
reduction of gastric juice volume and acidity is more beneficial 
to pregnant women [17]. Glycopyrrolate is consequently 
an ideal drug that can compensate CO reduction caused by 
phenylephrine administration. However, there are only a 
few reports on the appropriate dosage of glycopyrrolate. We 
selected 0.2 mg as the standard dosage. 
We found that SVI were similar compared to the baseline 
values between the two groups, which was in accordance with 
other studies. However, there were continuous decreases in 
HR caused by phenylephrine infusion, and HR decreased 
statistically from 8 min to 15 min in group P. In accordance with 
HR, there were continuous decreases in CI, and CI maximally 
decreased at 8 min (approximately 13%). Following that, CI 
recovered gradually, but there were statistically significant 
decreases compared with baseline values in group P. Although 
there were decreasing trends in HR until 8 min in group PG, HR 
recovered and was maintained. CI was similar to HR in group 
PG, and there was a maximum difference (0.5 L/min/m
2) at 9 
min between the two groups. 
This study showed that glycopyrrolate is an effective measure 
in maintaining HR and CI. 
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